nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Progesterone—uterine cancer	0.19	0.239	CbGbCtD
Tranylcypromine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0988	0.124	CbGbCtD
Tranylcypromine—CYP2C19—Progesterone—uterine cancer	0.0787	0.0988	CbGbCtD
Tranylcypromine—CYP1A2—Progesterone—uterine cancer	0.0726	0.0912	CbGbCtD
Tranylcypromine—CYP2C9—Progesterone—uterine cancer	0.0655	0.0821	CbGbCtD
Tranylcypromine—CYP2D6—Progesterone—uterine cancer	0.0599	0.0751	CbGbCtD
Tranylcypromine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0575	0.0721	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—uterine cancer	0.0562	0.0705	CbGbCtD
Tranylcypromine—CYP3A4—Progesterone—uterine cancer	0.0381	0.0478	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—uterine cancer	0.0325	0.0408	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—uterine cancer	0.0183	0.0229	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—uterine cancer	0.017	0.0214	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—uterine cancer	0.0116	0.0146	CbGbCtD
Tranylcypromine—Pollakiuria—Progesterone—uterine cancer	0.00145	0.00866	CcSEcCtD
Tranylcypromine—Drowsiness—Progesterone—uterine cancer	0.0014	0.00836	CcSEcCtD
Tranylcypromine—Body temperature increased—Carboplatin—uterine cancer	0.00135	0.00803	CcSEcCtD
Tranylcypromine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00785	CcSEcCtD
Tranylcypromine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00758	CcSEcCtD
Tranylcypromine—Haemoglobin—Progesterone—uterine cancer	0.00127	0.00755	CcSEcCtD
Tranylcypromine—Hepatitis—Progesterone—uterine cancer	0.00126	0.00751	CcSEcCtD
Tranylcypromine—Haemorrhage—Progesterone—uterine cancer	0.00126	0.00751	CcSEcCtD
Tranylcypromine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00726	CcSEcCtD
Tranylcypromine—Tinnitus—Progesterone—uterine cancer	0.00117	0.007	CcSEcCtD
Tranylcypromine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00693	CcSEcCtD
Tranylcypromine—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00684	CcSEcCtD
Tranylcypromine—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.0068	CcSEcCtD
Tranylcypromine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.0068	CcSEcCtD
Tranylcypromine—Alopecia—Progesterone—uterine cancer	0.00111	0.00663	CcSEcCtD
Tranylcypromine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00634	CcSEcCtD
Tranylcypromine—Muscle spasms—Progesterone—uterine cancer	0.00105	0.00628	CcSEcCtD
Tranylcypromine—Vision blurred—Progesterone—uterine cancer	0.00103	0.00616	CcSEcCtD
Tranylcypromine—Tremor—Progesterone—uterine cancer	0.00103	0.00612	CcSEcCtD
Tranylcypromine—MAOB—myometrium—uterine cancer	0.00102	0.0556	CbGeAlD
Tranylcypromine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0061	CcSEcCtD
Tranylcypromine—Anaemia—Progesterone—uterine cancer	0.00101	0.00604	CcSEcCtD
Tranylcypromine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00601	CcSEcCtD
Tranylcypromine—Syncope—Progesterone—uterine cancer	0.000983	0.00586	CcSEcCtD
Tranylcypromine—Palpitations—Progesterone—uterine cancer	0.000969	0.00577	CcSEcCtD
Tranylcypromine—Loss of consciousness—Progesterone—uterine cancer	0.000963	0.00574	CcSEcCtD
Tranylcypromine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000955	0.00569	CcSEcCtD
Tranylcypromine—Hypertension—Progesterone—uterine cancer	0.000946	0.00564	CcSEcCtD
Tranylcypromine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000931	0.00555	CcSEcCtD
Tranylcypromine—Anxiety—Progesterone—uterine cancer	0.00093	0.00554	CcSEcCtD
Tranylcypromine—Agranulocytosis—Dactinomycin—uterine cancer	0.000925	0.00552	CcSEcCtD
Tranylcypromine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000918	0.00547	CcSEcCtD
Tranylcypromine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.00544	CcSEcCtD
Tranylcypromine—Dry mouth—Progesterone—uterine cancer	0.000913	0.00544	CcSEcCtD
Tranylcypromine—Confusional state—Progesterone—uterine cancer	0.000902	0.00538	CcSEcCtD
Tranylcypromine—Oedema—Progesterone—uterine cancer	0.000895	0.00533	CcSEcCtD
Tranylcypromine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.00531	CcSEcCtD
Tranylcypromine—Hepatitis—Dactinomycin—uterine cancer	0.00089	0.00531	CcSEcCtD
Tranylcypromine—Shock—Progesterone—uterine cancer	0.00088	0.00525	CcSEcCtD
Tranylcypromine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000878	0.00523	CcSEcCtD
Tranylcypromine—MAOA—myometrium—uterine cancer	0.000874	0.0474	CbGeAlD
Tranylcypromine—Tachycardia—Progesterone—uterine cancer	0.000873	0.00521	CcSEcCtD
Tranylcypromine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000873	0.0052	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Progesterone—uterine cancer	0.000865	0.00516	CcSEcCtD
Tranylcypromine—Blood disorder—Epirubicin—uterine cancer	0.000861	0.00513	CcSEcCtD
Tranylcypromine—Anorexia—Progesterone—uterine cancer	0.000853	0.00508	CcSEcCtD
Tranylcypromine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000843	0.00502	CcSEcCtD
Tranylcypromine—Hypotension—Progesterone—uterine cancer	0.000836	0.00498	CcSEcCtD
Tranylcypromine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000827	0.00493	CcSEcCtD
Tranylcypromine—Flushing—Dactinomycin—uterine cancer	0.000826	0.00492	CcSEcCtD
Tranylcypromine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.00487	CcSEcCtD
Tranylcypromine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00483	CcSEcCtD
Tranylcypromine—Insomnia—Progesterone—uterine cancer	0.000809	0.00482	CcSEcCtD
Tranylcypromine—Paraesthesia—Progesterone—uterine cancer	0.000803	0.00479	CcSEcCtD
Tranylcypromine—Chills—Dactinomycin—uterine cancer	0.000799	0.00476	CcSEcCtD
Tranylcypromine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000798	0.00475	CcSEcCtD
Tranylcypromine—MAOB—uterine cervix—uterine cancer	0.000797	0.0432	CbGeAlD
Tranylcypromine—Blood disorder—Doxorubicin—uterine cancer	0.000797	0.00475	CcSEcCtD
Tranylcypromine—Somnolence—Progesterone—uterine cancer	0.000795	0.00474	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000794	0.00473	CcSEcCtD
Tranylcypromine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000791	0.00472	CcSEcCtD
Tranylcypromine—Alopecia—Dactinomycin—uterine cancer	0.000786	0.00469	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000784	0.00467	CcSEcCtD
Tranylcypromine—Decreased appetite—Progesterone—uterine cancer	0.000778	0.00464	CcSEcCtD
Tranylcypromine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000773	0.00461	CcSEcCtD
Tranylcypromine—Constipation—Progesterone—uterine cancer	0.000765	0.00456	CcSEcCtD
Tranylcypromine—Pain—Progesterone—uterine cancer	0.000765	0.00456	CcSEcCtD
Tranylcypromine—MAOB—decidua—uterine cancer	0.00076	0.0412	CbGeAlD
Tranylcypromine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000758	0.00452	CcSEcCtD
Tranylcypromine—MAOB—renal system—uterine cancer	0.000746	0.0405	CbGeAlD
Tranylcypromine—Feeling abnormal—Progesterone—uterine cancer	0.000737	0.00439	CcSEcCtD
Tranylcypromine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.00437	CcSEcCtD
Tranylcypromine—CYP2A6—vagina—uterine cancer	0.000732	0.0397	CbGeAlD
Tranylcypromine—Gastrointestinal pain—Progesterone—uterine cancer	0.000732	0.00436	CcSEcCtD
Tranylcypromine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00434	CcSEcCtD
Tranylcypromine—MAOB—endometrium—uterine cancer	0.000721	0.0391	CbGeAlD
Tranylcypromine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000721	0.0043	CcSEcCtD
Tranylcypromine—Anaemia—Dactinomycin—uterine cancer	0.000716	0.00427	CcSEcCtD
Tranylcypromine—Urticaria—Progesterone—uterine cancer	0.000711	0.00424	CcSEcCtD
Tranylcypromine—Body temperature increased—Progesterone—uterine cancer	0.000707	0.00422	CcSEcCtD
Tranylcypromine—Abdominal pain—Progesterone—uterine cancer	0.000707	0.00422	CcSEcCtD
Tranylcypromine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000705	0.0042	CcSEcCtD
Tranylcypromine—MAOB—mammalian vulva—uterine cancer	0.000697	0.0378	CbGeAlD
Tranylcypromine—Leukopenia—Dactinomycin—uterine cancer	0.000694	0.00413	CcSEcCtD
Tranylcypromine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000693	0.00413	CcSEcCtD
Tranylcypromine—MAOA—uterine cervix—uterine cancer	0.00068	0.0369	CbGeAlD
Tranylcypromine—Agranulocytosis—Etoposide—uterine cancer	0.00067	0.00399	CcSEcCtD
Tranylcypromine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00398	CcSEcCtD
Tranylcypromine—MAOB—uterus—uterine cancer	0.000664	0.036	CbGeAlD
Tranylcypromine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000663	0.00395	CcSEcCtD
Tranylcypromine—MAOA—decidua—uterine cancer	0.000648	0.0352	CbGeAlD
Tranylcypromine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000644	0.00384	CcSEcCtD
Tranylcypromine—Asthenia—Progesterone—uterine cancer	0.000642	0.00383	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Etoposide—uterine cancer	0.000641	0.00382	CcSEcCtD
Tranylcypromine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00382	CcSEcCtD
Tranylcypromine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00382	CcSEcCtD
Tranylcypromine—MAOA—renal system—uterine cancer	0.000636	0.0345	CbGeAlD
Tranylcypromine—Oedema—Dactinomycin—uterine cancer	0.000632	0.00377	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000619	0.00369	CcSEcCtD
Tranylcypromine—MAOA—endometrium—uterine cancer	0.000615	0.0334	CbGeAlD
Tranylcypromine—Diarrhoea—Progesterone—uterine cancer	0.000612	0.00365	CcSEcCtD
Tranylcypromine—Anorexia—Dactinomycin—uterine cancer	0.000603	0.00359	CcSEcCtD
Tranylcypromine—Flushing—Etoposide—uterine cancer	0.000598	0.00356	CcSEcCtD
Tranylcypromine—MAOB—female reproductive system—uterine cancer	0.000597	0.0324	CbGeAlD
Tranylcypromine—MAOA—mammalian vulva—uterine cancer	0.000595	0.0323	CbGeAlD
Tranylcypromine—Dizziness—Progesterone—uterine cancer	0.000592	0.00353	CcSEcCtD
Tranylcypromine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000582	0.00347	CcSEcCtD
Tranylcypromine—Chills—Etoposide—uterine cancer	0.000578	0.00345	CcSEcCtD
Tranylcypromine—Alopecia—Etoposide—uterine cancer	0.000569	0.00339	CcSEcCtD
Tranylcypromine—Vomiting—Progesterone—uterine cancer	0.000569	0.00339	CcSEcCtD
Tranylcypromine—MAOA—uterus—uterine cancer	0.000567	0.0308	CbGeAlD
Tranylcypromine—Rash—Progesterone—uterine cancer	0.000564	0.00336	CcSEcCtD
Tranylcypromine—Dermatitis—Progesterone—uterine cancer	0.000564	0.00336	CcSEcCtD
Tranylcypromine—Headache—Progesterone—uterine cancer	0.00056	0.00334	CcSEcCtD
Tranylcypromine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000555	0.00331	CcSEcCtD
Tranylcypromine—Decreased appetite—Dactinomycin—uterine cancer	0.00055	0.00328	CcSEcCtD
Tranylcypromine—MAOB—female gonad—uterine cancer	0.000543	0.0295	CbGeAlD
Tranylcypromine—Pain—Dactinomycin—uterine cancer	0.000541	0.00322	CcSEcCtD
Tranylcypromine—MAOB—vagina—uterine cancer	0.00054	0.0293	CbGeAlD
Tranylcypromine—Muscle spasms—Etoposide—uterine cancer	0.000539	0.00321	CcSEcCtD
Tranylcypromine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000536	0.0032	CcSEcCtD
Tranylcypromine—Nausea—Progesterone—uterine cancer	0.000531	0.00317	CcSEcCtD
Tranylcypromine—CYP1A2—renal system—uterine cancer	0.000531	0.0288	CbGeAlD
Tranylcypromine—Feeling abnormal—Dactinomycin—uterine cancer	0.000521	0.00311	CcSEcCtD
Tranylcypromine—Anaemia—Etoposide—uterine cancer	0.000518	0.00309	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000517	0.00308	CcSEcCtD
Tranylcypromine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000515	0.00307	CcSEcCtD
Tranylcypromine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000511	0.00305	CcSEcCtD
Tranylcypromine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000511	0.00304	CcSEcCtD
Tranylcypromine—MAOA—female reproductive system—uterine cancer	0.00051	0.0276	CbGeAlD
Tranylcypromine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000508	0.00303	CcSEcCtD
Tranylcypromine—Leukopenia—Etoposide—uterine cancer	0.000502	0.00299	CcSEcCtD
Tranylcypromine—Body temperature increased—Dactinomycin—uterine cancer	0.0005	0.00298	CcSEcCtD
Tranylcypromine—Abdominal pain—Dactinomycin—uterine cancer	0.0005	0.00298	CcSEcCtD
Tranylcypromine—Loss of consciousness—Etoposide—uterine cancer	0.000493	0.00294	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—uterine cancer	0.000491	0.00293	CcSEcCtD
Tranylcypromine—Hypertension—Etoposide—uterine cancer	0.000484	0.00289	CcSEcCtD
Tranylcypromine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000482	0.00287	CcSEcCtD
Tranylcypromine—CYP2E1—renal system—uterine cancer	0.000478	0.0259	CbGeAlD
Tranylcypromine—CYP2C19—vagina—uterine cancer	0.000471	0.0255	CbGeAlD
Tranylcypromine—MAOA—female gonad—uterine cancer	0.000464	0.0252	CbGeAlD
Tranylcypromine—Confusional state—Etoposide—uterine cancer	0.000461	0.00275	CcSEcCtD
Tranylcypromine—MAOA—vagina—uterine cancer	0.000461	0.025	CbGeAlD
Tranylcypromine—Ataxia—Doxorubicin—uterine cancer	0.000454	0.00271	CcSEcCtD
Tranylcypromine—Asthenia—Dactinomycin—uterine cancer	0.000454	0.0027	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Etoposide—uterine cancer	0.000448	0.00267	CcSEcCtD
Tranylcypromine—Tachycardia—Etoposide—uterine cancer	0.000447	0.00266	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Etoposide—uterine cancer	0.000442	0.00264	CcSEcCtD
Tranylcypromine—Anorexia—Etoposide—uterine cancer	0.000436	0.0026	CcSEcCtD
Tranylcypromine—Diarrhoea—Dactinomycin—uterine cancer	0.000433	0.00258	CcSEcCtD
Tranylcypromine—Hypotension—Etoposide—uterine cancer	0.000428	0.00255	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—uterine cancer	0.000417	0.00248	CcSEcCtD
Tranylcypromine—Paraesthesia—Etoposide—uterine cancer	0.000411	0.00245	CcSEcCtD
Tranylcypromine—Somnolence—Etoposide—uterine cancer	0.000407	0.00243	CcSEcCtD
Tranylcypromine—CYP2C9—female reproductive system—uterine cancer	0.000404	0.0219	CbGeAlD
Tranylcypromine—Drowsiness—Epirubicin—uterine cancer	0.000402	0.0024	CcSEcCtD
Tranylcypromine—Vomiting—Dactinomycin—uterine cancer	0.000402	0.0024	CcSEcCtD
Tranylcypromine—Rash—Dactinomycin—uterine cancer	0.000399	0.00238	CcSEcCtD
Tranylcypromine—Decreased appetite—Etoposide—uterine cancer	0.000398	0.00237	CcSEcCtD
Tranylcypromine—Pain—Etoposide—uterine cancer	0.000391	0.00233	CcSEcCtD
Tranylcypromine—Constipation—Etoposide—uterine cancer	0.000391	0.00233	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—uterine cancer	0.000386	0.0023	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—uterine cancer	0.000386	0.0023	CcSEcCtD
Tranylcypromine—CYP3A4—renal system—uterine cancer	0.000384	0.0208	CbGeAlD
Tranylcypromine—CYP2E1—female reproductive system—uterine cancer	0.000382	0.0208	CbGeAlD
Tranylcypromine—CYP2D6—renal system—uterine cancer	0.000378	0.0205	CbGeAlD
Tranylcypromine—Feeling abnormal—Etoposide—uterine cancer	0.000377	0.00225	CcSEcCtD
Tranylcypromine—Nausea—Dactinomycin—uterine cancer	0.000376	0.00224	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—uterine cancer	0.000375	0.00224	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Etoposide—uterine cancer	0.000374	0.00223	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—uterine cancer	0.000372	0.00222	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—uterine cancer	0.000368	0.00219	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—uterine cancer	0.000364	0.00217	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—uterine cancer	0.000363	0.00216	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—uterine cancer	0.000362	0.00216	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—uterine cancer	0.000362	0.00216	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—uterine cancer	0.000361	0.00215	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—uterine cancer	0.000361	0.00215	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—uterine cancer	0.000359	0.00214	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—uterine cancer	0.000357	0.00213	CcSEcCtD
Tranylcypromine—MAOB—lymph node—uterine cancer	0.000349	0.019	CbGeAlD
Tranylcypromine—Agranulocytosis—Doxorubicin—uterine cancer	0.000347	0.00207	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—uterine cancer	0.00034	0.00203	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—uterine cancer	0.000337	0.00201	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—uterine cancer	0.000336	0.002	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—uterine cancer	0.000335	0.002	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—uterine cancer	0.000334	0.00199	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—uterine cancer	0.000334	0.00199	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000332	0.00198	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—uterine cancer	0.000328	0.00196	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—uterine cancer	0.000324	0.00193	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—uterine cancer	0.000319	0.0019	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—uterine cancer	0.000313	0.00187	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—uterine cancer	0.000312	0.00186	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—uterine cancer	0.00031	0.00185	CcSEcCtD
Tranylcypromine—CYP3A4—female reproductive system—uterine cancer	0.000308	0.0167	CbGeAlD
Tranylcypromine—CYP2D6—female reproductive system—uterine cancer	0.000303	0.0164	CbGeAlD
Tranylcypromine—Dizziness—Etoposide—uterine cancer	0.000303	0.0018	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—uterine cancer	0.000302	0.0018	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—uterine cancer	0.0003	0.00179	CcSEcCtD
Tranylcypromine—MAOA—lymph node—uterine cancer	0.000298	0.0162	CbGeAlD
Tranylcypromine—Vision blurred—Epirubicin—uterine cancer	0.000296	0.00177	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—uterine cancer	0.000295	0.00176	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—uterine cancer	0.000291	0.00173	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—uterine cancer	0.000291	0.00173	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—uterine cancer	0.000289	0.00172	CcSEcCtD
Tranylcypromine—Rash—Etoposide—uterine cancer	0.000289	0.00172	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—uterine cancer	0.000288	0.00172	CcSEcCtD
Tranylcypromine—Headache—Etoposide—uterine cancer	0.000287	0.00171	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—uterine cancer	0.000282	0.00168	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—uterine cancer	0.000281	0.00168	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—uterine cancer	0.00028	0.00167	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—uterine cancer	0.000278	0.00166	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—uterine cancer	0.000276	0.00165	CcSEcCtD
Tranylcypromine—CYP2D6—female gonad—uterine cancer	0.000276	0.015	CbGeAlD
Tranylcypromine—Vision blurred—Doxorubicin—uterine cancer	0.000274	0.00163	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—uterine cancer	0.000272	0.00162	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—uterine cancer	0.000271	0.00162	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—uterine cancer	0.000269	0.0016	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—uterine cancer	0.000267	0.00159	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—uterine cancer	0.000267	0.00159	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—uterine cancer	0.000262	0.00156	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—uterine cancer	0.000261	0.00155	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—uterine cancer	0.00026	0.00155	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—uterine cancer	0.000259	0.00154	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—uterine cancer	0.000257	0.00153	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—uterine cancer	0.000257	0.00153	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—uterine cancer	0.000256	0.00152	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—uterine cancer	0.000252	0.0015	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—uterine cancer	0.000251	0.0015	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—uterine cancer	0.000251	0.0015	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—uterine cancer	0.00025	0.00149	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—uterine cancer	0.000248	0.00148	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—uterine cancer	0.000247	0.00147	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—uterine cancer	0.000245	0.00146	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—uterine cancer	0.000242	0.00144	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—uterine cancer	0.00024	0.00143	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—uterine cancer	0.000239	0.00143	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—uterine cancer	0.000237	0.00142	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—uterine cancer	0.000234	0.00139	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000232	0.00139	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—uterine cancer	0.000232	0.00138	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—uterine cancer	0.000232	0.00138	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—uterine cancer	0.00023	0.00137	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000229	0.00137	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—uterine cancer	0.000228	0.00136	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—uterine cancer	0.000226	0.00135	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—uterine cancer	0.000223	0.00133	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—uterine cancer	0.000222	0.00132	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—uterine cancer	0.000219	0.00131	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—uterine cancer	0.000219	0.00131	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—uterine cancer	0.000215	0.00128	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—uterine cancer	0.000213	0.00127	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—uterine cancer	0.000211	0.00126	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—uterine cancer	0.000211	0.00126	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—uterine cancer	0.00021	0.00125	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—uterine cancer	0.000206	0.00123	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—uterine cancer	0.000204	0.00121	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—uterine cancer	0.000203	0.00121	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—uterine cancer	0.000203	0.00121	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—uterine cancer	0.000203	0.00121	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—uterine cancer	0.000203	0.00121	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—uterine cancer	0.000196	0.00117	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000194	0.00116	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—uterine cancer	0.000189	0.00112	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—uterine cancer	0.000188	0.00112	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—uterine cancer	0.000188	0.00112	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—uterine cancer	0.000184	0.0011	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—uterine cancer	0.000176	0.00105	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—uterine cancer	0.00017	0.00102	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—uterine cancer	0.00017	0.00101	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—uterine cancer	0.000163	0.000972	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—uterine cancer	0.000162	0.000968	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—uterine cancer	0.000162	0.000964	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—uterine cancer	0.000162	0.000963	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—uterine cancer	0.000161	0.000958	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—uterine cancer	0.000157	0.000936	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—uterine cancer	0.000152	0.000908	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—uterine cancer	0.000151	0.0009	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—uterine cancer	0.00015	0.000892	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—uterine cancer	0.00015	0.000891	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—uterine cancer	0.000149	0.000886	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—uterine cancer	0.000141	0.000841	CcSEcCtD
Tranylcypromine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	6.74e-05	0.00398	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	6.65e-05	0.00393	CbGpPWpGaD
Tranylcypromine—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	6.61e-05	0.00391	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	6.58e-05	0.00389	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	6.55e-05	0.00388	CbGpPWpGaD
Tranylcypromine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.53e-05	0.00386	CbGpPWpGaD
Tranylcypromine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	6.51e-05	0.00385	CbGpPWpGaD
Tranylcypromine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.47e-05	0.00383	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	6.2e-05	0.00367	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	6.19e-05	0.00366	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	6.19e-05	0.00366	CbGpPWpGaD
Tranylcypromine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	5.8e-05	0.00343	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	5.7e-05	0.00337	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	5.66e-05	0.00334	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	5.64e-05	0.00333	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.53e-05	0.00327	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	5.47e-05	0.00323	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	5.45e-05	0.00322	CbGpPWpGaD
Tranylcypromine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.27e-05	0.00311	CbGpPWpGaD
Tranylcypromine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.2e-05	0.00307	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	5.13e-05	0.00303	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	5.08e-05	0.00301	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	5.06e-05	0.00299	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	5.01e-05	0.00296	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	4.97e-05	0.00294	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKR1B1—uterine cancer	4.93e-05	0.00292	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—STAR—uterine cancer	4.93e-05	0.00292	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	4.89e-05	0.00289	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	4.83e-05	0.00286	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	4.82e-05	0.00285	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	4.78e-05	0.00282	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	4.72e-05	0.00279	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	4.67e-05	0.00276	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	4.65e-05	0.00275	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	4.61e-05	0.00273	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.55e-05	0.00269	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	4.39e-05	0.0026	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	4.35e-05	0.00257	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NDUFB11—uterine cancer	4.28e-05	0.00253	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—SRD5A2—uterine cancer	4.28e-05	0.00253	CbGpPWpGaD
Tranylcypromine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.27e-05	0.00252	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	4.24e-05	0.00251	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.15e-05	0.00245	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CXCL8—uterine cancer	4.01e-05	0.00237	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	3.99e-05	0.00236	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	3.94e-05	0.00233	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—POLD1—uterine cancer	3.87e-05	0.00229	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	3.83e-05	0.00227	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.83e-05	0.00227	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.77e-05	0.00223	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.73e-05	0.00221	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	3.72e-05	0.0022	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.72e-05	0.0022	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	3.7e-05	0.00219	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKR1C1—uterine cancer	3.62e-05	0.00214	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.55e-05	0.0021	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.47e-05	0.00205	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	3.44e-05	0.00203	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—EP300—uterine cancer	3.44e-05	0.00203	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.42e-05	0.00202	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	3.39e-05	0.00201	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.37e-05	0.00199	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.37e-05	0.00199	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NDUFB11—uterine cancer	3.32e-05	0.00197	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SRD5A2—uterine cancer	3.32e-05	0.00197	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.29e-05	0.00195	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.29e-05	0.00195	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.27e-05	0.00194	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—VEGFA—uterine cancer	3.25e-05	0.00192	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—RRM2—uterine cancer	3.23e-05	0.00191	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.19e-05	0.00188	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.15e-05	0.00186	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—DCN—uterine cancer	3.13e-05	0.00185	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—STAR—uterine cancer	3.1e-05	0.00183	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKR1B1—uterine cancer	3.1e-05	0.00183	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.08e-05	0.00182	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.04e-05	0.0018	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3e-05	0.00177	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3e-05	0.00177	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP11A1—uterine cancer	2.95e-05	0.00175	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.94e-05	0.00174	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.9e-05	0.00171	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.87e-05	0.0017	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKR1C3—uterine cancer	2.79e-05	0.00165	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.71e-05	0.0016	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.63e-05	0.00155	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.63e-05	0.00155	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.56e-05	0.00152	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.56e-05	0.00152	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—POLD1—uterine cancer	2.43e-05	0.00144	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.42e-05	0.00143	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKR1B1—uterine cancer	2.4e-05	0.00142	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—STAR—uterine cancer	2.4e-05	0.00142	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.3e-05	0.00136	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKR1C1—uterine cancer	2.27e-05	0.00134	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.27e-05	0.00134	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.24e-05	0.00132	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.2e-05	0.0013	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—STK11—uterine cancer	2.17e-05	0.00128	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP19A1—uterine cancer	2.17e-05	0.00128	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.03e-05	0.0012	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.03e-05	0.0012	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—RRM2—uterine cancer	2.03e-05	0.0012	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.97e-05	0.00116	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—DCN—uterine cancer	1.97e-05	0.00116	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—HRAS—uterine cancer	1.93e-05	0.00114	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—STAR—uterine cancer	1.9e-05	0.00112	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKR1B1—uterine cancer	1.9e-05	0.00112	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—POLD1—uterine cancer	1.89e-05	0.00112	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.88e-05	0.00111	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.86e-05	0.0011	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.86e-05	0.0011	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.86e-05	0.0011	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP11A1—uterine cancer	1.85e-05	0.0011	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.85e-05	0.00109	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.85e-05	0.00109	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.8e-05	0.00106	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKR1C1—uterine cancer	1.76e-05	0.00104	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKR1C3—uterine cancer	1.75e-05	0.00103	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.7e-05	0.001	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—MTHFR—uterine cancer	1.63e-05	0.000965	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.58e-05	0.000934	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.58e-05	0.000934	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—RRM2—uterine cancer	1.57e-05	0.00093	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.53e-05	0.000907	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—DCN—uterine cancer	1.53e-05	0.000903	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—POLD1—uterine cancer	1.49e-05	0.000881	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—HRAS—uterine cancer	1.48e-05	0.000873	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.47e-05	0.000866	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—STAR—uterine cancer	1.47e-05	0.000866	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.45e-05	0.000857	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.45e-05	0.000856	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.44e-05	0.00085	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.39e-05	0.000824	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—STK11—uterine cancer	1.36e-05	0.000806	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP19A1—uterine cancer	1.36e-05	0.000806	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.36e-05	0.000803	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—STAR—uterine cancer	1.35e-05	0.000797	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.35e-05	0.000797	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—STAR—uterine cancer	1.34e-05	0.00079	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.34e-05	0.00079	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.32e-05	0.000781	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—RRM2—uterine cancer	1.24e-05	0.000735	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.22e-05	0.000721	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.22e-05	0.000721	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—DCN—uterine cancer	1.21e-05	0.000713	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—POLD1—uterine cancer	1.15e-05	0.00068	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.14e-05	0.000675	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—STAR—uterine cancer	1.14e-05	0.000675	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.14e-05	0.000672	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.13e-05	0.000667	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.08e-05	0.000636	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.07e-05	0.000635	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—STK11—uterine cancer	1.06e-05	0.000626	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.06e-05	0.000626	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—POLD1—uterine cancer	1.06e-05	0.000625	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—POLD1—uterine cancer	1.05e-05	0.00062	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—MTHFR—uterine cancer	1.02e-05	0.000606	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKR1C1—uterine cancer	9.89e-06	0.000585	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKR1C1—uterine cancer	9.81e-06	0.00058	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—RRM2—uterine cancer	9.59e-06	0.000567	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—DCN—uterine cancer	9.31e-06	0.00055	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTEN—uterine cancer	9.08e-06	0.000537	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—POLD1—uterine cancer	8.96e-06	0.00053	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—RRM2—uterine cancer	8.82e-06	0.000521	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—STAR—uterine cancer	8.81e-06	0.000521	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.81e-06	0.000521	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP11A1—uterine cancer	8.77e-06	0.000518	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—RRM2—uterine cancer	8.74e-06	0.000517	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—EP300—uterine cancer	8.66e-06	0.000512	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—DCN—uterine cancer	8.56e-06	0.000506	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—DCN—uterine cancer	8.49e-06	0.000502	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKR1C1—uterine cancer	8.38e-06	0.000496	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—STK11—uterine cancer	8.36e-06	0.000494	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP19A1—uterine cancer	8.36e-06	0.000494	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKR1C3—uterine cancer	8.28e-06	0.00049	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP11A1—uterine cancer	8.06e-06	0.000477	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.99e-06	0.000473	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MTHFR—uterine cancer	7.95e-06	0.00047	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKR1C3—uterine cancer	7.62e-06	0.00045	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKR1C3—uterine cancer	7.55e-06	0.000446	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—RRM2—uterine cancer	7.47e-06	0.000442	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—DCN—uterine cancer	7.25e-06	0.000429	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—POLD1—uterine cancer	6.91e-06	0.000409	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.83e-06	0.000404	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.47e-06	0.000382	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.45e-06	0.000381	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—STK11—uterine cancer	6.45e-06	0.000381	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.45e-06	0.000381	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CA—uterine cancer	6.41e-06	0.000379	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—uterine cancer	6.28e-06	0.000372	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.06e-06	0.000358	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—STK11—uterine cancer	5.93e-06	0.000351	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.93e-06	0.000351	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.88e-06	0.000348	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—STK11—uterine cancer	5.88e-06	0.000348	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.77e-06	0.000341	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—RRM2—uterine cancer	5.76e-06	0.000341	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTEN—uterine cancer	5.7e-06	0.000337	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—DCN—uterine cancer	5.6e-06	0.000331	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.52e-06	0.000326	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—EP300—uterine cancer	5.43e-06	0.000321	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.27e-06	0.000312	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.27e-06	0.000311	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—uterine cancer	5.23e-06	0.000309	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—STK11—uterine cancer	5.03e-06	0.000297	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP19A1—uterine cancer	5.03e-06	0.000297	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.98e-06	0.000294	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—uterine cancer	4.85e-06	0.000287	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.72e-06	0.000279	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.5e-06	0.000266	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—uterine cancer	4.46e-06	0.000264	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTEN—uterine cancer	4.42e-06	0.000262	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—uterine cancer	4.42e-06	0.000261	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.27e-06	0.000253	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—EP300—uterine cancer	4.22e-06	0.000249	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CA—uterine cancer	4.02e-06	0.000238	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.89e-06	0.00023	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—STK11—uterine cancer	3.88e-06	0.000229	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.88e-06	0.000229	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—uterine cancer	3.78e-06	0.000223	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTEN—uterine cancer	3.5e-06	0.000207	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—EP300—uterine cancer	3.33e-06	0.000197	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.33e-06	0.000197	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—uterine cancer	3.28e-06	0.000194	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CA—uterine cancer	3.12e-06	0.000185	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.91e-06	0.000172	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTEN—uterine cancer	2.7e-06	0.000159	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—EP300—uterine cancer	2.57e-06	0.000152	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—uterine cancer	2.55e-06	0.000151	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTEN—uterine cancer	2.48e-06	0.000147	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.47e-06	0.000146	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTEN—uterine cancer	2.46e-06	0.000145	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—EP300—uterine cancer	2.37e-06	0.00014	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—EP300—uterine cancer	2.34e-06	0.000139	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTEN—uterine cancer	2.1e-06	0.000124	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—uterine cancer	2.01e-06	0.000119	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—EP300—uterine cancer	2e-06	0.000118	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.9e-06	0.000112	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.75e-06	0.000103	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.73e-06	0.000103	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTEN—uterine cancer	1.62e-06	9.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—uterine cancer	1.55e-06	9.19e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—EP300—uterine cancer	1.55e-06	9.14e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.48e-06	8.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—uterine cancer	1.43e-06	8.45e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—uterine cancer	1.42e-06	8.38e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—uterine cancer	1.21e-06	7.16e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.14e-06	6.76e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—uterine cancer	9.35e-07	5.53e-05	CbGpPWpGaD
